Johnson & Johnson (JNJ) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Johnson & Johnson’s (NYSE: JNJ) stock price can continue to advance because its strategy to reinvigorate growth and widen margins is working. The plan centers on divesting underperforming healthcare ...

Johnson & Johnson (NYSE:JNJ) is included among the 13 Best Defensive Dividend Stocks for 2025. On March 3, BofA analyst Jason Gerberry raised the firm’s price recommendation on Johnson & Johnson (NYSE ...

What Is Driving the New Fair Value Estimate for Johnson & Johnson? The fair value estimate for Johnson & Johnson has shifted from about US$224.09 to roughly US$231.25 per share, and the revenue growth ...

With a market cap of $592.4 billion, New Brunswick, New Jersey-based Johnson & Johnson (JNJ)is a global healthcare company ...

The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and ...

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But when you're an income investor, your primary ...

Johnson & Johnson (JNJ), Chevron (CVX), Realty Income (O), Broadcom (AVGO), and Agree Realty (ADC) for income investors.